Abstract:Early prediction of clearance mechanisms allows for the rapid progression of drug discovery and development programs, and facilitates risk assessment of the pharmacokinetic variability associated with drug interactions and pharmacogenomics. Here we propose a scientific framework – Extended Clearance Classification System (ECCS) – which can be used to predict the predominant clearance mechanism (rate-determining process) based on physicochemical properties and passive membrane permeability. Compounds are classified as: Class 1A – metabolism as primary systemic clearance mechanism (high permeability acids/zwitterions with molecular weight (MW) ≤400 Da), Class 1B – transporter-mediated hepatic uptake as primary systemic clearance mechanism (high permeability acids/zwitterions with MW >400 Da), Class 2 – metabolism as primary clearance mechanism (high permeability bases/neutrals), Class 3A –renal clearance (low permeability acids/zwitterions with MW ≤400 Da), Class 3B – transporter mediated hepatic uptake or renal clearance (low permeability acids/zwitterions with MW >400 Da), and Class 4 – renal clearance (low permeability bases/neutrals). The performance of the ECCS framework was validated using 307 compounds with single clearance mechanism contributing to ≥70% of systemic clearance. The apparent permeability across clonal cell line of Madin − Darby canine kidney cells, selected for low endogenous efflux transporter expression, with a cut-off of 5 × 10−6 cm/s was used for permeability classification, and the ionization (at pH7) was assigned based on calculated pKa. The proposed scheme correctly predicted the rate-determining clearance mechanism to be either metabolism, hepatic uptake or renal for ~92% of total compounds. We discuss the general characteristics of each ECCS class, as well as compare and contrast the framework with the biopharmaceutics classification system (BCS) and the biopharmaceutics drug disposition classification system (BDDCS). Collectively, the ECCS framework is valuable in early prediction of clearance mechanism and can aid in choosing the right preclinical tool kit and strategy for optimizing drug exposure and evaluating clinical risk of pharmacokinetic variability caused by drug interactions and pharmacogenomics.

Classification Tree Model for Drug Penetrability Classification Identification of Biopharmaceutics Classification System

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

Simulation-based comparison of Biopharmaceutics Classification System and drug structure

[Research and development thought on biopharmaceutics classification system of Chinese materia medica].

Introduction of Biopharmaceutics Classification System(bcs)and Its Application Progress

[Biopharmaceuticals classification system(BCS) of nuciferin in Nelumbinis Folium]

ADME Properties Evaluation in Drug Discovery: Prediction of Caco-2 Cell Permeability Using a Combination of NSGA-II and Boosting

[Research on attributes of biopharmaceutics classification system for Chinese materia medica of baicalein in Gegen Qinlian Decoction environment].

Prediction of blood‐brain barrier permeability using machine learning approaches based on various molecular representation

Classification Tree Models for the Prediction of Blood—Brain Barrier Passage of Drugs.

The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension

Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)

Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.

Prediction of BBB Permeation Based on Molecular Indices

QSPR Study on the Permeability of Drugs Across Caco-2 Monolayer

[Biopharmaceutics classification system of Chinese materia medica of berberine in Gegen Qinlian decoction]

A Predictive Model for Blood-Brain Barrier Penetration

Estimation of ADME Properties with Substructure Pattern Recognition

Predictive modeling of skin permeability for molecules: Investigating FDA-approved drug permeability with various AI algorithms

Application prospect of biopharmaceutical classification system based on drug solubility and permeability determination in veterinary drug development

Advance in the research of biological penetration enhancers in transdermal drug delivery system